Andrea Sloan, ‘Poster Child’ For Compassionate Use, Gets A Drug

See on Scoop.itResources For People Living With A Cancer Diagnosis & Their Families & Care-Partners

“One of the more contentious and high-profile fights over compassionate use in recent years may be drawing to a close. Andrea Sloan, who spent the past two months battling with BioMarin Pharmaceutical over access to a drug that she hoped to use to treat her Stage 3c ovarian cancer, says that she has been granted compassionate use by another company that she declines to name at its request.*

“These past months have been an amazing journey – exhilarating and exhausting all at once. While I have been pursuing one option, life has graced me with another.  After months of hoping and praying, I am finally getting access to a promising new therapy to treat my progressing cancer,” says the 45-year-old attorney for a non-profit in Texas that works with survivors of domestic violence and abuse.

As we reportedly previously, BioMarin is currently testing a so-called PARP inhibitor – a protein that helps repair breaks in DNA – but enrollment in the ovarian arm of the study is supposedly closed. Although the FDA certified Sloan for compassionate use, BioMarin repeatedly refused to provide the treatment to her and expressed concerns that its experimental BMN-673 may not be safe or effective.”

Heather Swift‘s insight:

Andrea Sloan is able to get the drug that can save her life from another company which name was not disclosed at their request. I am so happy she can get the PARP Inhibitor. Thank you to everyone who signed her petition.

See on


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: